Completed PHASE2 INTERVENTIONAL 3-arm NCT00753025

Autologous Bone Marrow For Lower Extremity Ischemia Treating

Randomized Double Blind Placebo-Controlled Research Of Treatment Efficiency For Patients With Lower Extremity Arteriosclerosis Obliterans By Autologous Transplantation Of Bone Marrow Progenitor Cells

Sponsor: Clinical Center of Cellular Technologies, Russia

Conditions Lower Extremity Ischemia

Interventions Bone marrow aspiration , injection of isolated CD 133+ cells Bone marrow aspiration, injection of cells Bone marrow aspiration, injection of saline

Updated 6 times since 2017 Last updated: Sep 15, 2008 Started: Oct 31, 2006 Primary completion: Jun 30, 2007 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lower Extremity Ischemia, this trial is completed. The trial is conducted by Clinical Center of Cellular Technologies, Russia and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Apr 2018 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE2

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Center of Cellular Technologies, Russia
Regional hospital of Samara
Samara State Medical University

Data source: Clinical Center of Cellular Technologies, Russia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.